ReviewRSC advances2025
Evolution in the synthesis of 1,4-benzothiazines over the last decade (2014 to 2024).
Review in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
1,4-Benzothiazine (1,4-BT) is a heterocyclic compound consisting of a benzene ring fused with a thiazine ring, incorporating both nitrogen and sulfur atoms. The fusion of the benzene and thiazine frameworks enhances its biological properties, making it a valuable scaffold for designing innovative heterocyclic systems. This versatile and significant member of the heteroarene family bridges synthetic organic chemistry with medicinal, pharmaceutical, and industrial applications. This structural motif demonstrates remarkable potential for accommodating a wide range of substrates and functionalizations, giving rise to diverse biological activities such as antipsychotropic, antiviral, antithyroid, antimicrobial, antifungal, antitubercular, antioxidant, and anti-inflammatory properties. Numerous derivatives have been synthesized as target structures in drug development. This review highlights various synthetic approaches to prepare 1,4-BTs. Well-established methods, such as the reactions of 2-aminothiophenol (2-ATP) with alkenes, enaminones, carboxylic acids, esters, furan-2,3-dione, aroylmethylidene malonate and 1,3-dicarbonyl compounds, are summarized. Additionally, the miscellaneous syntheses of 1,4-BTs were also outlined. These methods have utilized various catalysts, including nanocatalysts and metal-based catalysts, under diverse reaction conditions for efficient synthesis. The deep analysis of the synthesis of 1,4-BTs will grasp the scientific community towards their synthetic aspects and further advances in the field.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.